BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15763135)

  • 21. Enhanced dopamine uptake in the striatum following repeated restraint stress.
    Copeland BJ; Neff NH; Hadjiconstantinou M
    Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to identify monoamine transporter interacting proteins.
    Torres GE; Caron MG
    J Neurosci Methods; 2005 Apr; 143(1):63-8. PubMed ID: 15763137
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute ethanol decreases dopamine transporter velocity in rat striatum: in vivo and in vitro electrochemical measurements.
    Robinson DL; Volz TJ; Schenk JO; Wightman RM
    Alcohol Clin Exp Res; 2005 May; 29(5):746-55. PubMed ID: 15897718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens.
    Cedeño N; Urbina M; Obregón F; Lima L
    J Neuroimmunol; 2005 Feb; 159(1-2):31-40. PubMed ID: 15652400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
    Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA
    J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation.
    Ikeda T; Kurosawa M; Uchikawa C; Kitayama S; Nukina N
    Biochem Biophys Res Commun; 2005 Feb; 327(1):218-24. PubMed ID: 15629452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dopamine transporter: role in neurotoxicity and human disease.
    Bannon MJ
    Toxicol Appl Pharmacol; 2005 May; 204(3):355-60. PubMed ID: 15845424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The up-regulation of the striatal dopamine transporter's activity by cAMP is PKA-, CaMK II- and phosphatase-dependent.
    Page G; Barc-Pain S; Pontcharraud R; Cante A; Piriou A; Barrier L
    Neurochem Int; 2004 Oct; 45(5):627-32. PubMed ID: 15234104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragmentation pathway of dopamine transporter ligands: N-substituted-2beta-carbomethoxy-3beta-phenylnortropane derivatives.
    Mavel S; Abarbri M; Frangin Y; Duchène A; Emond P
    J Pharm Biomed Anal; 2004 Apr; 35(1):193-8. PubMed ID: 15030894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
    Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
    J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sp1 and Sp3 activate transcription of the human dopamine transporter gene.
    Wang J; Bannon MJ
    J Neurochem; 2005 Apr; 93(2):474-82. PubMed ID: 15816870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
    Meiergerd SM; McElvain JS; Schenk JO
    Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
    Byas-Smith MG; Li J; Szlam F; Eaton DC; Votaw JR; Denson DD
    Synapse; 2004 Aug; 53(2):68-73. PubMed ID: 15170819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
    Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
    J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
    Kimura M; Masuda T; Yamada K; Kawakatsu N; Kubota N; Mitani M; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4287-90. PubMed ID: 15261288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
    Earles C; Wayment H; Green M; Schenk JO
    Methods Enzymol; 1998; 296():660-75. PubMed ID: 9779481
    [No Abstract]   [Full Text] [Related]  

  • 37. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ
    Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying monoamine transporters: beyond hypermonoaminaemia.
    Reith ME
    J Neurosci Methods; 2005 Apr; 143(1):1-2. PubMed ID: 15763131
    [No Abstract]   [Full Text] [Related]  

  • 39. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry.
    Greco PG; Garris PA
    Eur J Pharmacol; 2003 Oct; 479(1-3):117-25. PubMed ID: 14612143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.